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Neuro-ophthalmologic exploration in non-functioning pituitary adenoma
Explorations neuro-ophtalmologiques d’un adénome hypophysaire non fonctionnel
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bstract
Non-functioning pituitary adenoma may lead to blindness and causes visual impairment in 58% of cases and, more rarely, ocular motor disorder.
atients are slow to become aware of their visual dysfunction, vision in one eye compensating the deficit in the other. Assessment of visual
unction, comprising visual acuity and visual field evaluation and fundus examination, should be performed regularly according to the severity of
mpairment. Optic nerve optical coherence tomography (OCT) can quantify optic atrophy reproducibly, and is of prognostic value for postoperative
isual recovery. Diplopia most often involves decompensation of heterophoria, visual field fusion being hampered by the visual field defect; such
iplopia without ocular motor deficit is known as “hemifield slide”. Diplopia associated with ocular motor palsy is caused by tumoral invasion
f the cavernous sinus (IIIrd, IVth or VIth nerve palsy); in large impairment, restricted eye movement is easily observed; milder palsies require
euro-ophthalmologic assessment and/or Lancaster test. Pituitary apoplexy induces ocular motor impairment in 70% of cases, strongly guiding
iagnosis. Visual impairment is associated in 75% of cases. The degree of neuro-ophthalmologic (visual and ocular motor) impairment is one of
he main criteria guiding treatment of pituitary apoplexy (conservative medical and/or surgical treatment) and follow-up.
 2015 Published by Elsevier Masson SAS.
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ésuméLes adénomes hypophysaires non fonctionnels, pathologie potentiellement cécitante, sont responsables d’atteinte visuelle dans 58 % des cas et
lle est longtemps asymptomatique, par compensation de l’œil controlatéral.lus rarement de troubles oculomoteurs. L’atteinte de la fonction visuel est nécessaire d’effectuer une évaluation de l’acuité visuelle, du champ visuel et du fond d’œil de manière régulière, la fréquence dépendant
e la sévérité de l’atteinte (entre tous les 3 à 6 mois au début). L’optical  coherence  tomography  (OCT) du nerf optique peut compléter le bilan, et
omporte une valeur reproductible, de suivi et pronostique, sur la récupération post-opératoire. Les diplopies les plus fréquentes sont en général
iées à la décompensation de phories par le déficit du champ visuel, avec une perte de la capacité fusionnelle, sans déficit oculomoteur, et portent
e nom de « glissement de l’hémichamp ». En cas de paralysie oculomotrice, l’atteinte est liée à l’envahissement du sinus caverneux par la tumeur
paralysie du III, du IV, ou du VI). Lorsque le déficit est important, une limitation des mouvements de l’œil est facilement observée. Lorsqu’il est
inime, il nécessite un bilan orthoptique et/ou un test de Lancaster. En cas d’apoplexie pituitaire, l’atteinte oculomotrice, qui est présente dans
DOIs of original articles: http://dx.doi.org/10.1016/j.ando.2015.04.004, http://dx.doi.org/10.1016/j.ando.2015.04.002,
ttp://dx.doi.org/10.1016/j.ando.2015.04.005, http://dx.doi.org/10.1016/j.ando.2015.04.007, http://dx.doi.org/10.1016/j.ando.2015.04.003
 Consensus of the French Endocrine Society: non-functioning pituitary adenoma.
∗ Corresponding author at: Unité de neuro-ophtalmologie, service de neurologie D, hôpital neurologique, hospices civils de Lyon, groupement hospitalier Est,
9, boulevard Pinel, 69500 Bron, France.
E-mail address: lucie.abouaf@chu-lyon.fr (L. Abouaf).
http://dx.doi.org/10.1016/j.ando.2015.04.006
003-4266/© 2015 Published by Elsevier Masson SAS.
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0 % des cas, prédomine et est fortement évocatrice. Une baisse visuelle associée est observée dans 75 % des cas d’apoplexie. L’importance de
’atteinte neuro-ophtalmologique (visuelle et oculomotrice) est un des éléments essentiels dans le choix du traitement (médical conservateur et/ou
hirurgical), ainsi que dans le suivi de cette pathologie.
 2015 Publié par Elsevier Masson SAS.
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.  Introduction
Non-functioning pituitary adenoma (NFPA) is a major source
f visual disorders, and is diagnosed later than functioning ade-
oma, often with larger tumor volume. Incidence of NFPA was
8–33.2% in pituitary adenoma populations, with or without
isual involvement [1,2], but 58% in case of pituitary ade-
oma specifically with visual involvement [3]. Patients may
e unaware of their deficit, especially in case of bitemporal
emianopsia, as functioning visual field in one eye can long
ompensate for visual field loss in the other.
Ocular motor impairment is mainly due to compression or
nvasion of the cavernous sinus, and is more frequent in case of
arge pituitary adenoma.
Finally, neuro-ophthalmologic involvement is critical in pitu-
tary apoplexy, very frequently associating visual disorder,
cular motor disorder and headache of exceptionally sudden
nset or with rapid progression.
The present paper will deal successively with visual involve-
ent (acuity and visual field), ocular motor disorder, and
euro-ophthalmologic involvement in pituitary apoplexy.
.  Visual  impairment
.1.  Anatomic  bases
The visual impairment is caused by compression of the ante-
ior visual pathways (optic nerves, chiasm, optic tracts) by the
denoma. The anatomic position of the anterior visual pathways
ith respect to the pituitary gland varies greatly from individual
o individual, as does tumor orientation. Thus, while compres-
ion is usually chiasmal, it may also involve one or both optic
erves anteriorly or optic tract(s) posteriorly.
The ganglion-cell fibers that constitute the optic nerve change
n spatial relation between the origin (in the inner retinal layers)
nd termination (in the lateral geniculate body).
Their organization in the retina and head of the optic nerve
s as follows (Fig. 1): the fibers of the nasal retinal hemifield
temporal visual hemifield) are shown in blue and are distributed
ver the entire circumference of the optic nerve head when they
each it (blind-spot). The fibers of the temporal retinal hemifield
nasal visual hemifield) are shown in pink and are mainly located
t the superior and inferior poles of the optic nerve head.
Along the optic nerve, the fibers gradually shift, bringing
ogether those of a given quadrant of the visual field, with fibers
orresponding to the superior and inferior temporal fields on the
nside, ready to decussate, and those corresponding to the supe-
ior and inferior nasal fields remaining on the outside (Fig. 2).
p
n
b
iation du champ visuel ; Diplopie
A simplified diagram of fiber distribution (Fig. 3) is enough
o explain the visual disorders induced by pituitary adenoma. At
he chiasm, the ganglion cell fibers corresponding to the tempo-
al hemifield of either eye cross the midline into the contralateral
ptic tract, while those corresponding to the nasal hemifield enter
he ipsilateral tract, without decussation. Thus, visual informa-
ion corresponding to the right hemifield is entirely encoded in
he left optic tract, and vice-versa. Fibers encoding the superior
emporal hemifield, when they cross over, initially head for the
ontralateral optic nerve before joining the contralateral tract;
amage to these fibers is the source of the junctional Traquair
yndrome (junctional scotoma) (cf. “Initial assessment”, below).
.2.  Pathophysiology
Contact between a pituitary adenoma and the anterior visual
athways is not in itself of visual impact. It is compression
hat induces visual disorder; the compression, however, is not
easurable and is only indirectly suspected on imaging, as dis-
lacement of the visual pathways in contact with the tumor is
resent.
Several mechanisms are implicated in onset of visual impair-
ent; initially reversible, they become irreversible. Reversible
unctional mechanisms comprise axoplasmic flow disorder,
onduction blockage and demyelinization. Irreversible mech-
nisms consist in axonal fiber degeneration under longer and/or
ore intense compression. This is seen in the fundus as optic
trophy; the level of redundancy of ganglion cell fibers forming
he optic nerve and encoding visual information, however, means
hat a small degree of atrophy may be without functional impact,
eaving visual acuity and the visual field normal. Advanced optic
trophy, on the other hand, induces lasting deficit, even after
ompression has been relieved by surgery.
.3.  Initial  assessment
Ophthalmologic assessment includes visual acuity, pupil and
undus examination, ocular motor assessment and examination
or ptosis (including cover test ±  Hess-Weiss coordimetric graph
f necessary) and visual field assessment. The rest of the usual
phthalmologic assessment protocol (refraction, intra-ocular
ressure, anterior segment slit-lamp examination, retinal exam-
nation) is also systematically performed, as other ophthalmic
athologies may interfere with the tumor-induced deficits:
otably, severe myopia and tilted disc syndrome may mimic
itemporal visual field defect (Fig. 4A and B), and need to be
dentified.
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Fig. 1. Retinal organization of ganglion-cell fibers from retinal origin to optic nerve head (left eye, fundus view). ON: optic nerve.
Fig. 2. Evolution of ganglion-cell fiber distribution along the anterior visual pathways according to visual field region encoded.
Fig. 3. Simplified diagram of the anterior visual pathways and chiasmal decussation. A bundle coding for the superior temporal field advances toward the contralateral
optic nerve at decussation; this underlies the junctional Traquair syndrome (junctional scotoma).
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2ig. 4. A. Bitemporal hemianopsia due to chiasmal compression by pituitary
emianopsia due to severe myopia. The defect limit seems vertical, but does no
.3.1.  Visual  ﬁeld  assessment
The visual field assessment is classically an automatic visual
eld test, enabling quantified assessment of defect, test reli-
bility and foveal threshold (i.e., macular region sensitivity) for
omparison with visual acuity data. Although the test routinely
ssesses only the central 24–30◦, it detects the vast majority of
efects induced by pituitary adenoma. Several devices may be
sed (Humphrey, Octopus and Métrovision being the most com-
on in France), providing comparable results. The Goldmann
isual field test assesses the periphery up to 90◦ laterally; it is
ainly used in case of severely impaired acuity or with non-
ompliant patients, and is also useful in suspected junctional
cotoma (involving the optic nerve immediately next to the chi-
sm), comprising a defect of the visual field ipsilateral to the
ompressed nerve associated with superior temporal peripheral
efect in the contralateral eye (Fig. 5), corresponding to a bun-
le of fibers from the eye contralateral to the lesion which, just
efore the chiasmal cross-over, advance slightly within the optic
erve ipsilateral to the lesion. This clinical presentation has the
nterest of specifying location of the compressive lesion.
w
ooma. Note that the defici stops at the vertical meridian. B. False bitemporal
w the vertical meridian, which passes through the center of vision.
.3.2.  Optical  coherence  tomography  (OCT)  of  the  optic
erve head
Optical Coherence Tomography (OCT) of the optic nerve
ead is usually performed in case of visual impairment, for pro-
nostic purposes. It is a non-invasive ocular imaging technique,
ithout contact, based on infrared light (820 nm), enabling in-
ivo assessment of eye tissue structure. The RNFL (retinal nerve
ber layer) module quantitatively estimates the number of gan-
lion cell axons constituting the optic nerve; this is a means
f quantifying optic nerve atrophy, whereas the pale aspect of
he nerve head in the fundus is subjective and non-quantifiable.
nalysis provides a mean RNFL value and values per quadrant
temporal, nasal, superior and inferior). The prognostic value of
his examination is discussed below.
.4.  Follow-upIf the tumor is in contact with the anterior visual pathways
ithout having any visual impact (visual acuity, visual field,
cular motor examination), yearly or 2-yearly ophthalmologic
214 L. Abouaf et al. / Annales d’Endocrinologie 76 (2015) 210–219
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rig. 5. Visual field assessment illustrating junctional Traquair syndrome (junc
cotoma, leaving an island of nasal vision; in the left eye, there is a superior tem
onitoring according to tumor growth kinetics is recommended.
he risk for visual function is slight, except in case of pituitary
poplexy.
If visual function is impaired, treatment is often considered.
f general health status precludes etiological treatment, ophthal-
ologic examination should be repeated within 3 to 4 months.
The kinetics of post-surgical visual recovery comprises sev-
ral phases. Kerrison et al. [4] identified three. The early
hase, up to 1 month postoperatively, corresponds pathophys-
ologically to release of the conduction block caused by the
ompression; cases of severe visual field defect resolving by
 week have been described. The second phase, between 1 and
 months, is the phase of remyelinization. In the late phase,
etween 4 months and 3 years, improvement continues, although
ess strongly, thanks to the same mechanisms plus possible
euronal plasticity effects within the anterior visual pathways.
nanalingham et al. [5] followed up 41 patients for 5 years, with
ery precise quantitative study of visual field defect, and found
isual field improvement up to end of follow-up, more than 50%
f the improvement taking place within 6 months.
The rhythm of postoperative ophthalmologic surveillance has
ot been a focus of published guidelines. We recommend post-
perative consultation at 3 months, then every 4 to 6 months
ntil visual function stabilizes; annual examination may then be
ursued. Each consultation should include visual acuity assess-
ent, pupil and fundus examination, visual field test and ocular
otor examination as well as standard ophthalmologic exami-
ation. It is important to perform all visual field tests in the same
lace and on the same apparatus, to allow comparison.
.5.  Prognostic  factors
Numerous prognostic factors for visual recovery have been
tudied, but with contradictory findings. The most reliable pro-
nostic factor to date would seem to be RNFL on OCT [6]:
he thinner the RNFL at diagnosis, the greater the optic atro-
hy and the greater the expected visual defect after treatment.
a
a
v scotoma). Points not perceived are shown in white. There is a huge right-eye
l scotoma.
n a series of 37 eyes in patients presenting pituitary adenoma
n contact with the anterior visual pathways and operated on by
 trans-sphenoidal approach, RNFL was strongly prognostic of
isual field recovery at 3 months: complete recovery of defect at
 months was associated with RNFL not significantly different
han controls, whereas eyes without recovery at 3 months had
ignificantly thinner RNFL than control eyes, eyes with 3-month
ecovery or eyes without initial defect despite adenoma contact
ith the anterior visual pathways. The prognostic value of the
NFL was thus established: for the mid-RNFL, the odds ratio
or complete recovery of visual field defect at 3 months was 1.29
er 1  increment (P  = 0.037). This effect was independent of the
ffects of age and interval between symptom onset and surgery
n multivariate analysis. The inferior RNFL showed very strong
rognostic value, with an odds ratio of 6.31 (P  = 0.0001) per 1 
ncrement [6].
Reported predictive values of preoperative visual field defect
everity for poor postoperative recovery are variable [3,5]. Good
reoperative acuity is predictive of good final recovery of acuity
ccording to certain reports [3] but not others [7], and the situa-
ion is the same for age [3,5–7]. Preoperative symptom duration
as a negative impact on recovery according to certain stud-
es [6], but appeared correlated with severity of preoperative
eficit in others [3]. Non-functioning tumors showed variable
ssociation with poorer recovery [3,8].
Electrophysiologically, the N95 component of the pattern-
lectroretinogram (ERG) reflects ganglion-cell activity in the
entral 15◦ of the visual field. A study of patients operated on
ia an endocranial approach or endoscopically for various types
f sellar region tumor (meningioma, adenoma) compressing the
hiasm [9] reported a probability of postoperative improvement
n the visual field of 26.97% when the preoperative N95/P50
atio was abnormal, versus 64.91% in case of normal ratio. More
ecently, another flash-ERG parameter reflecting ganglion-cell
ctivity, the photopic negative response (PhNR), was studied,
gain in patients with various types of sellar tumor operated on
ia an endocranial approach or endoscopically [10]; the ratio
ndocrinologie 76 (2015) 210–219 215
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etween PhNR and B-wave amplitude correlated strongly with
isual field defect severity at 3 months. Electrophysiological
ssessment, however, probably gives more negative results than
CT, being a functional approach that takes account not only of
he lack of function in ganglion cells that have actually degen-
rated but also of dysfunction at potentially reversible stages.
.  Ocular  motor  impairment
Ocular motor impairment associated with large pituitary ade-
oma is of three types: ocular motor restriction (1 or both eyes
oving poorly in certain directions of gaze), which is rare com-
ared to visual field defect (< 5% of cases) other than in the
articular context of pituitary apoplexy [11]; even rarer, abnor-
al eye movement, notably see-saw nystagmus; and dorsal
idbrain syndrome, in very large tumors compressing the upper
rainstem.
.1.  Parenthesis:  dysphoric  diplopia  without  ocular  motor
estriction
Before turning to true ocular motor impairment, a reminder
hould be given of the frequent onset of episodes of diplopia
ithout ocular motor restriction, associated with visual field dis-
rders preventing effective fusion of images from the two eyes.
iplopia without ocular motor restriction is more frequent than
cular motor restriction [12] and is known as “hemifield slide”.
rom the images coming from either eye, the brain superimposes
he visual fields areas common to the two. This enables perfect
lignment of the eyes, so that the corresponding retinal areas
n effect perceive one and the same image. In bitemporal hemi-
nopsia, there is no longer a shared area of vision, the right eye
erceiving only the left hemifield and vice-versa. This prevents
he motor command of alignment, and each eye falls into its
natomic rest position, which varies from individual to individ-
al. In exophoria (each eye tending to turn to outward), patients
erceive a central overlap between the nasal hemifields without
eing able to achieve fusion, inducing a sensation of diplopia.
n esophoria (the eyes spontaneously tending to cross), patients
ay perceive separate nasal hemifields, resulting in a vertical
entral scotoma in binocular vision [13].
.2.  Anatomic  bases  of  ocular  motor  impairment
Ocular motor restriction is due to lesions to ocular motor
erves III (common ocular motor nerve), IV (trochlear nerve)
nd VI (abducens nerve) between brainstem and orbit. In pitu-
tary adenoma, the lesion is usually in the cavernous sinus
Fig. 6).
The cavernous sinus is a large confluence of veins lying on
ither side of the sella turcica, which contains the pituitary gland.
t constitutes the lateral wall of the sella. The ophthalmic veins
nd sphenoparietal sinus in particular terminate in the cavernous
inus. There are vascular (internal carotid artery) and neural
tructures (all three ocular motor nerves [III, IV and VI], the
phthalmic nerve [V1], the inferolateral portion of the maxil-
ary nerve [V2] and the sympathetic contingent innervating the
t
c
s
iFig. 6. Diagram of cavernous sinus, coronal cross-section.
ye [14–16] and inducing Bernard Horner syndrome in case of
esion).
See-saw nystagmus is due to compression of the
iencephalic-mesencephalic region at the interstitial nucleus of
ajal or rostral interstitial nucleus of the medial longitudinal
asciculus (Fig. 7) [17–19]. These nuclei are involved in ocular
otor control.
Finally, dorsal midbrain syndrome results from compression
f the superior and posterior midbrain, which may also be asso-
iated with hydrocephalus by compression of the 3rd ventricle.
.3.  Pathophysiology  of ocular  motor  impairment
It should be borne in mind that ocular motor impairment
trongly suggests pituitary apoplexy, being exceptionally found
t diagnosis of macroadenoma [11]. Several pathophysiologi-
al hypotheses have been put forward to explain ocular motor
erve involvement. One concerns direct compression of the
erve by the tumor, or indirect compression through the wall
f the cavernous sinus [20]; the indirect mechanism is more
ikely in case of rapid tumor growth, as in apoplexy, follow-
ng intra-tumoral hemorrhage or tumoral ischemic infarction.
ocation is usually in the cavernous sinus, but some authors
ave hypothesized nerve compression in the oculomotor trigone
roof of the cavernous sinus), limited laterally by the anterior
etroclinoid ligament, medially by a line above the interclinoid
igament and posteriorly by the posterior petroclinoid ligament
16], supposedly a dural weak-spot [21]. Finally, in very large
umors, ocular motor nerve compression may also be exerted
n the brainstem or subarachnoid spaces [22]. Other hypotheses
ppeal to possible infiltration of the nerve by the tumor [22], or
schemia by vascular occlusion of the perforating arteries [23].
Of the 3 ocular motor nerves (III, IV and VI), the common
cular motor nerve (III) is the most frequently involved [24].
t enters the cavernous sinus via the oculomotor trigone with
 mediolateral course towards the superior orbital fissure. At
he roof of the sinus, where III enters, there is a whole cistern of
erebrospinal fluid (as the nerve is accompanied by an arachnoid
heet), and this cistern represents a possible route for tumor
nfiltration or extension [22,25,26]. Moreover, III lies in the same
216 L. Abouaf et al. / Annales d’Endocrinologie 76 (2015) 210–219
Fig. 7. Anatomic diagram of brainstem ocular motor centers. For easier read-
ing, the ocular motor nerve course has been shifted downward at the pituitary
gland: the nerves actually pass much nearer the gland, in the cavernous sinus, on
either side. riMLF: rostral interstitial nucleus of the medial longitudinal fasci-
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Fig. 8. Decision tree for the management of pituitary apoplexy, taken from UK
Guidelines for management of pituitary apoplexy. The authors do not see isolated
ocular motor palsy as an indication for surgery, even without improvement over
t
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lulus; PPRF: paramedian pontine reticular formation; NPH: nucleus prepositus
ypoglossi.
orizontal plane as the pituitary gland and is the most medial
cular motor nerve (Fig. 8); pressure induced by lateral extension
f the tumor is thus exerted on III at an early stage [23,27–30].
owever, III is rarely involved in isolation, although some such
ases have been reported [23,31–34]. Nerves IV and VI are less
ften involved than III [24,28,35]. IV is protected at its entry
nto the cavernous sinus by a doubling of the dura mater, and
I enters via an osteodural canal through the posterior wall,
orello’s canal [28,36,37]. Fourth and VIth nerves are mostly
ffected in case of massive compression of the cavernous sinus,
nvolving all the ocular motor nerves [38].
.4.  Initial  ocular  motor  assessment
.4.1.  Ocular  motor  restriction
Ocular motor restriction leads to diplopia when gaze isocused in the field of action of the paralyzed muscle. How-
ver, this is only true if visual acuity is good enough in both
yes.
p
m
[he first days of observation.
41].
Nerve III innervates the superior, inferior and medial rectus
uscles, the inferior oblique, levator palpebrae superioris (leva-
or muscle) and iris sphincter muscle. Complete nerve III palsy
nduces complete ptosis with paralyzed elevation, lowering and
dduction of the eye and mydriasis. Partial nerve III palsy is
requent, inducing partial or complete palsy in only some of the
uscles innervated by the nerve. Nerve IV innervates the supe-
ior oblique, and palsy impairs lowering of the eye in low and
edial gaze. Nerve VI innervates the lateral rectus and palsy
nduces abduction deficit.
The initial examination raises the question of “possible
iplopia” and ocular motor examination is performed as part
f ophthalmologic assessment in sellar tumor. The important
arameters for assessment here are version (conjoint movement
f both eyes), duction (movement eye by eye), cover test mea-
uring the deviation with prisms and pupil examination. The
ess-Weiss coordimetric graph reproducibly measures ocular
otor defects and may be combined with cover test.
.4.2. See-saw  nystagmus
See-saw nystagmus comprises a cycle of elevation and intor-
ion of one eye with synchronous depression and extorsion of
he other, followed by an inverse cycle. It may induce symptoms
uch as oscillopsia (trembling image sensation) [39].
.4.3. Other  manifestations
Certain large tumors may also induce hydrocephalus, poste-
ior expansion toward the 3rd ventricle blocking cerebrospinal
uid circulation. Papilloedema is then due more to this hydro-
ephalus than to tumor volume as such.
There may also exceptionally be dorsal midbrain syndrome,
ssociating one or more of the following: Parinaud’s syndrome
gaze elevation defect); nystagmus retractorius; abnormal eye-
id position (ptosis or retraction of the upper eyelids); abnormal
upil size, pupil dissociation in light and in convergence; accom-
odation disorder; convergence disorder; and skew deviation
40].
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.5.  Follow-up
Follow-up examinations are similar to initial assessment: his-
ory taking and ocular motor, vision and fundus examination,
ess-Weiss coordimetric graph and visual field test. In case of
ajor discrepancy between the two eyes, occluding one eye is
he only means of relieving the patient’s diplopia. If discrepancy
ersists long after treatment, surgical displacement of the ocu-
ar motor muscles may, very exceptionally, be proposed. If the
iscrepancy is moderate, prisms can be adapted: provisionally
tuck on the patient’s lenses at first and then definitively included
n the lenses when stability is achieved at a suitable interval after
reatment. In all cases, the objective is to relieve diplopia in pri-
ary position and in lowered gaze, but it is usually not possible
o restore single vision in all directions of gaze.
.6.  Prognostic  factors
The prognostic factors for ocular motor disorder associated
ith non-secreting pituitary adenoma are not known except in
he case of pituitary apoplexy (see below).
.  Pituitary  apoplexy
Neuro-ophthalmologic signs are in the forefront of the clin-
cal presentation of pituitary apoplexy, with sudden visual loss
nd/or ocular motor palsy. Frequently, headache, which may
ften be intense and sudden, is associated. Visual impairment
s found in 75% of cases, secondary to a sudden increase in the
ize of the pre-existing adenoma [41]. It is, however, noteworthy
hat there is often already optic atrophy at diagnosis. For exam-
le, optic atrophy was found in 7/14 cases of pituitary apoplexy
nducing total visual loss [42]; as several months of anterior
isual pathway compression are needed to induce optic atro-
hy, it is easy to see that visual impairment is already advanced
lthough not consciously experienced by the patient at onset of
poplexy. Ocular motor palsy occurs in almost 70% of cases
41]. The third nerve is the most frequently involved, in 50%
f patients with cranial nerve involvement, followed by VIth
erve palsy, then IVth nerve palsy, then Vth nerve palsy [43].
erve dysfunction is caused by compression of the cavernous
inus and the nerves within it secondary to a sudden increase in
umor size. Unlike the anterior visual pathways, the ocular motor
erves, when affected, induce diplopia, which quickly leads to
onsultation. As most patients are asymptomatic prior to pitu-
tary apoplexy, it may be supposed that the ocular motor nerves
resented little or no dysfunction prior to this acute event.
The type and severity of neuro-ophthalmologic involve-
ent guide treatment options: non-operative or surgical, and
ime to surgery if any. However, given the rarity of pitu-
tary apoplexy, no prospective studies have been feasible; the
etrospective studies had several biases: the severity of neuro-
phthalmologic involvement differed between surgical and
on-operative groups, vitiating prognostic comparison; time to
urgery was highly variable, and reasons for postponing surgery
ere not always explained; finally, almost all series were small.
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Surgery is almost certainly indicated in severe neuro-
phthalmologic involvement (affecting acuity and/or visual
eld), showing progression or associated with disorder of con-
ciousness; in “moderate neuro-ophthalmologic involvement”,
n the other hand, there is no consensus as to the role of sim-
le medical management, and indeed the concept of “moderate
euro-ophthalmologic involvement” is not clearly defined.
Ayuk et al., in 2004 [44], seemed to validate medical manage-
ent of mild neuro-ophthalmologic involvement. Non-operative
reatment was implemented in 33 pituitary apoplexy patients,
ith surgery reserved for visual deterioration or worsened neu-
ologic status. Surgery was performed within 22 days in 14 out
f the 15 cases managed surgically; 18 patients were managed
edically. Seven of the 18 patients managed medically pre-
ented with ocular motor palsy and 6 with visual field defect;
ll showed complete recovery. Eight of the 15 patients managed
urgically showed ocular motor involvement, with total regres-
ion in 63% of cases, and 7 showed visual field defect, resolved
n 57% of cases at end of follow-up (mean follow-up, 3.78 years;
ange, 0.4–10.1 years). Severity of ophthalmologic involvement
as not compared between groups, preventing comparison of
reatments but nevertheless validating the safety of a strategy
eserving surgery to cases of clinical deterioration. Other studies
eem to show similar results [45].
A retrospective study by Leyer et al. in 2011 [46] included
4 patients, managed surgically or medically, with 4 undergoing
econdary surgery after primary medical care. Primary surgery
as indicated for severity of visual impairment or consciousness
isorder, although the criteria of visual severity were not speci-
ed. Again, medical management seemed to provide satisfactory
euro-ophthalmologic results, but comparison is meaningless
iven the baseline differences between groups.
The interest of early intervention when surgery is indicated
s more a matter of common sense for a compressive pathol-
gy such as pituitary apoplexy than an evidence-based attitude.
he Oxford series [47] was one of the first to compare neuro-
phthalmologic performances between early (within 8 days of
nset) and late surgery (at 9–34 days). In this retrospective
eries, medical management was reserved to cases free of visual
nvolvement. Recovery of visual acuity was complete in 100%
f patients operated on within 8 days but only 46% of those
perated on later, 31% showing partial recovery and 23% no
ecovery. The evolution of the visual field and ocular motor func-
ion also seemed more favorable with early surgery. However,
he main bias of this retrospective study was a lack of data on
he degree of neuro-ophthalmologic deficit according to group,
itiating comparison.
Woo et al., in 2010, reported similar results in a retrospective
eries of 12 patients, but again without data on baseline deficit
etween the early and late surgery groups [43]. There was a sig-
ificant correlation (P  = 0.0286) between apoplexy-to-surgery
nterval and time to postoperative cranial nerve recovery, argu-
ng for early intervention. Kim et al., in 2007, also supported the
ypothesis that time to surgery is a prognostic factor for speed
f recovery of ocular motor palsy [37].
Other than early treatment, Chuang et al., in 2011, also sug-
ested that absence of afferent pupillary defect and low-intensity
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cular motor signs are factors of good ocular motor recovery
48].
In complete loss of vision (negative light perception) in acute
ituitary apoplexy, visual prognosis is poor, but a certain degree
f recovery may occur [49]. In a retrospective series of 7 patients
14 eyes) with complete loss of vision secondary to pituitary
poplexy [42], optic atrophy was found at diagnosis in 7 patients,
estifying to optic nerve involvement prior to apoplexy; 3 eyes
chieved final 10/10 acuity. Recovery seemed to be better with
arly surgery.
In the light of the scientific evidence available and the expe-
ience of physicians and surgeons treating pituitary apoplexy,
he UK Guidelines for Management of Pituitary Apoplexy [41]
ecommend the decision tree shown in Fig. 8.
.  Conclusion
Management of pituitary adenoma is necessarily multidisci-
linary. It is therefore important for each endocrinologist to be
n close contact with a local ophthalmologist aware of the issues
nvolved in pituitary pathology. Ophthalmologic assessment will
hus be earlier and complete, including visual field test and ocu-
ar misalignment measures. The patient’s file will be collated
y the ophthalmologist, who should take care to distinguish the
espective roles of the pituitary adenoma and other concomi-
ant ophthalmic pathologies. Treatment is basically etiological,
ut symptomatic treatment, notably in case of diplopia, may be
ndertaken by the ophthalmologist and assistant.
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